|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1935687042 |
| 003 |
DE-627 |
| 005 |
20230517032846.0 |
| 007 |
tu |
| 008 |
140129s2014 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw140128_1
|
| 035 |
|
|
|a (DE-627)OLC1935687042
|
| 035 |
|
|
|a (DE-599)GBVOLC1935687042
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 570
|a 610
|
| 084 |
|
|
|a PHARM
|2 fid
|
| 084 |
|
|
|a XA 24552
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.43
|2 bkl
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 100 |
1 |
|
|a Locher, Hans H.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
|
| 264 |
|
1 |
|c 2014
|
| 300 |
|
|
|a 8
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Caspers, Patrick
|4 oth
|
| 700 |
1 |
|
|a Bruyre, Thierry
|4 oth
|
| 700 |
1 |
|
|a Schroeder, Susanne
|4 oth
|
| 700 |
1 |
|
|a Pfaff, Philippe
|4 oth
|
| 700 |
1 |
|
|a Knezevic, Andreja
|4 oth
|
| 700 |
1 |
|
|a Keck, Wolfgang
|4 oth
|
| 700 |
1 |
|
|a Ritz, Daniel
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Antimicrobial agents and chemotherapy
|d Washington, DC : American Society for Microbiology, 1962
|g 58(2014), 2 vom: Feb., Seite 901-908
|w (DE-627)129542318
|w (DE-600)217602-6
|w (DE-576)01499142X
|x 0066-4804
|7 nnns
|
| 773 |
1 |
8 |
|g volume:58
|g year:2014
|g number:2
|g month:02
|g pages:901-908
|g extent:8
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-PHARM
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4112
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a XA 24552
|
| 936 |
b |
k |
|a 44.38
|q AVZ
|
| 936 |
b |
k |
|a 44.43
|q AVZ
|
| 936 |
b |
k |
|a 44.40
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 58
|j 2014
|e 2
|c 2
|h 901-908
|g 8
|
